Description
Cytotoxic agents, integral to cancer treatment, are pharmaceuticals designed to inhibit or destroy cells, particularly cancerous ones, by impeding their rapid growth and division. In the realm of Central Nervous System (CNS) pharmaceuticals, the focus is on developing medications for disorders affecting the brain and spinal cord, including epilepsy, Alzheimer's disease, and psychiatric conditions. These advancements in both cytotoxic and CNS drugs play a crucial role in enhancing treatment options and improving the overall well-being of individuals grappling with cancer and neurological disorders.